Transatlantic tensions over access to COVID-19 vaccines mount after Sanofi CEO says US is first in queue

French pharmaceutical company Sanofi is at the centre of a transatlantic row over access to its COVID-19 vaccines, after CEO Paul Hudson said the US would get “first access, because it was first to fund the research.” French politicians slammed the remarks by Sanofi’s (British) CEO Paul Hudson, who told…

This content is for Corporate Members and Individual Members only.
Log In Register